Ignite Creation Date:
2025-12-25 @ 2:01 AM
Ignite Modification Date:
2026-02-10 @ 1:43 AM
Study NCT ID:
NCT02385760
Status:
COMPLETED
Last Update Posted:
2016-08-02
First Post:
2015-03-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CTX-4430 for the Treatment of Moderate to Severe Facial Acne Vulgaris
Sponsor:
Celtaxsys, Inc.
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CTX-4430-AV-201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None